Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-01-02 Sale |
2025-01-03 4:15 pm |
Xilio Therapeutics Inc. | XLO | Brennan Kevin M. SVP, FINANCE AND ACCOUNTING |
1,803 | $0.9837 | $1,774 | 78,197 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-01-01 Exercise |
2025-01-03 4:15 pm |
N/A N/A |
Xilio Therapeutics Inc. | XLO | Brennan Kevin M. SVP, FINANCE AND ACCOUNTING |
5,000 | $0 | 78,197 (Direct) |
View |
| 2025-01-01 Option Award |
2025-01-03 4:15 pm |
N/A 2035-12-31 |
Xilio Therapeutics Inc. | XLO | Brennan Kevin M. SVP, FINANCE AND ACCOUNTING |
60,000 | $0 | 78,197 (Direct) |
View |
| 2024-10-01 Option Award |
2024-10-02 5:15 pm |
N/A 2034-09-30 |
Xilio Therapeutics Inc. | XLO | Brennan Kevin M. SVP, FINANCE AND ACCOUNTING |
26,000 | $0 | 26,000 (Direct) |
View |
| 2024-05-01 Option Award |
2024-05-03 4:10 pm |
N/A 2034-04-30 |
Xilio Therapeutics Inc. | XLO | Brennan Kevin M. SVP, FINANCE AND ACCOUNTING |
20,000 | $0 | 20,000 (Direct) |
View |
| 2024-01-01 Option Award |
2024-01-03 4:15 pm |
N/A N/A |
Xilio Therapeutics Inc. | XLO | Brennan Kevin M. SVP, FINANCE AND ACCOUNTING |
20,000 | $0 | 20,000 (Direct) |
View |
| 2023-08-16 Option Award |
2023-08-18 8:35 pm |
N/A 2033-08-15 |
Xilio Therapeutics Inc. | XLO | Brennan Kevin M. SVP, FINANCE AND ACCOUNTING |
25,000 | $0 | 25,000 (Direct) |
View |
| 2023-04-01 Option Award |
2023-04-03 4:11 pm |
N/A 2033-03-31 |
Xilio Therapeutics Inc. | XLO | Brennan Kevin M. SVP, FINANCE AND ACCOUNTING |
55,000 | $0 | 55,000 (Direct) |
View |